With increasing information overload and packed work schedules, staying up-to-date on the newest oncologic advances is harder than ever. But take heart! The QuadShot is freshly brewed in your inbox four mornings each week so you can quickly down and digest the day's most pertinent cancer news.
To the chagrin of tort lawyers everywhere, this report demonstrates pathogenic germline mutations are present in over 1 in 10 patients with mesothelioma. As expected, germline mutations were even more common among younger patients with little asbestos exposure. | Panou, J Clin Oncol 2018